General Information
Version
5.8. Revision Date
Revision date
2026-09-14
Product name
6-chlorophenanthridine
Product name
6-chlorophenanthridine
Identification on the label/Trade name
BBV-45061304
1.2.1 Relevant identified uses
of the substance and restrictions on use
supplier name
ENAMINE Ltd
Emergency telephone
+380 44 5373218, +380 44 5373253
Icons in SDS
Company Information
company name
ENAMINE Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
SDS@enamine.net
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H301, H311, H331
Hazard statements
Code
Statements
H301
Toxic if swallowed
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008] Classification of the substance / mixture
Hazard pictograms
� � � � � � � � � �
Signal word
Danger
Hazard statements
H301 Toxic if swalloed H311 Toxic in contact with skin H331 Toxic if inhaled
Precautionary statements
P261 Avoid breathing dust/fume/gas/mist/vapours/spray. P264 Wash hands thoroughly after handling. Wash skin thouroughly after handling. P270 Do not eat, drink or smoke when using this product. P271 Use only outdoors or in a well-ventilated area. P280 Wear protective gloves/protective clothing/eye protection/face protection. P302+P352 IF ON SKIN: wash with plenty of soap and water. P304+P340 IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. P310 Immediately call a POISON CENTER or doctor/physician. P330 Rinse mouth. P361 Remove/Take off immediately all contaminated clothing. P403+P233 Store in a well-ventilated place. Keep container tightly closed. P405 Store locked up. P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Other hazards
N/A
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 Acute toxicity, oral(Category 3), H301 Acute toxicity, dermal(Category 3), H311 Acute toxicity, inhalation(Category 3), H331 For the full text of the H-Statements mentioned in this Section, see Section 2.2.
